Therefore, regardless of TIDE, immune dysfunction, CAF, and CD274 scores, patients in the high MMP score group consistently had better survival than those in the low, indicating the value of the MMP score in predicting the therapeutic effect on ICB. Here, CD274 is linked to immune system disorder.